SynthesisFrontiers in immunology2026
First-line immunotherapy for advanced hepatocellular carcinoma: a network meta-analysis of randomized trials with overall and HBV/HCV-stratified efficacy and safety.
Wei Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.